Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Applied Molecular Evolution

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve healthcare by discovering, optimizing and developing human biotherapeutics. Since its inception, AME’s principal focus has been on applying its proprietary AMEsystem™ technology platform to the full range of protein therapeutic candidates including antibodies, cytokines, hormones and enzymes to develop novel human biotherapeutic candidates.
Since February 2004, AME has been a wholly-owned subsidiary of Eli Lilly and Company and is an integral part of Lilly’s research organization. Lilly, a leading innovation-driven corporation is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Lilly provides answers – through medicines and information – for some of the world’s most urgent medical needs.

While geographically separate, AME works closely with Lilly colleagues in Indianapolis and around the world, sharing a corporate legacy of integrity and commitment to quality that spans more than a century.


Contact Details:
3520 Dunhill street
San Diego
California
92121
United States of America
Tel:858.597.4990
Fax:858.597.4950
Email:
WWW:

www.ame.biz/




Loading...

Recent Publications by Applied Molecular Evolution:

Peptide membranes in chemical evolution.
Simple surfactants achieve remarkable long-range order in aqueous...
3rd November, 2009
Center for Fundamental and Applied Molecular Evolution and the Center for Curr Opin Chem Biol. 2009 Oct 28.
DOI Direct Link
Templating molecular arrays in amyloid's cross-beta grooves.
Amyloid fibers, independent of primary amino acid sequence, share a common...
15th October, 2009
Center for Fundamental and Applied Molecular Evolution, and Department of J Am Chem Soc. 2009 Jul 29;131(29):10165-72.
DOI Direct Link
The molecular language of semagenesis.
Semagenesis, the process of signal generation, is a novel signaling...
26th August, 2009
Center for Fundamental and Applied Molecular Evolution; Emory University Plant Signal Behav. 2008 Aug;3(8):560-1.
How evolving enzymes can beat the heat and avoid defeat.
Semagenesis, the process of signal generation, is a novel signaling...
8th August, 2009
Department of Biochemistry, Center for Fundamental and Applied Molecular Nat Chem Biol. 2009 Aug;5(8):538-9.
DOI Direct Link
2'-deoxy-1-methylpseudocytidine, a stable analog of 2'-deoxy-5-methylisocytidine.
2'-deoxy-5-methylisocytidine is widely used in assays to personalize the...
1st July, 2009
Westheimer Institute for Science and Technology, Foundation for Applied Bioorg Med Chem. 2009 May 15;17(10):3728-32. Epub 2009 Mar 27.
DOI Direct Link

View more Applied Molecular Evolution research publications.

Press Releases on Applied Molecular Evolution:

BioPortfolio Logo
Reportlinker Adds Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment 26th October, 2009 Reportlinker
-- A focus on "engineered" antibodies Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment reviews the broad drug development effort that is focused on bringing
MorphoSys Reports third quarter 2004 results. Company expects to obtain 1st September, 2004 Morphosys
MorphoSys Reports third quarter 2004 results. Company expects to obtain profitablity by 2005 Martinsried/Munich, October 28, 2004 MorphoSys AG (Frankfurt Stock Exchange: MOR; Prime

BioNews Results for Applied Molecular Evolution:

Eli Lilly Units Pumping Up Drug Pipeline
San Diego Business Journal:  Nov 9 2009 5:50PM Matching: applied molecular evolution
Biotech Blooms at Eli Lilly
Cafepharma:  Nov 9 2009 4:56PM Matching: applied molecular evolution
Biotech Blooms at Eli Lilly
Seeking Alpha:  Nov 8 2009 4:44PM Matching: applied molecular evolution
Lilly Opens Biotech Center in San Diego
Lab Manager:  Nov 3 2009 4:12PM Matching: applied molecular evolution
Eli Lilly and Company Opens Eco-Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance
Pharma Live:  Nov 3 2009 7:16AM Matching: applied molecular evolution
Promote your company here: BioNewsCast - Press Release Distribution

View more Applied Molecular Evolution news.

Applied Molecular Evolution Clinical Trials:

A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma

Applied Molecular Evolution Patents:

US Patent No.Title
7575747 A.beta. binding molecules
6787638 Tumor specific human monoclonal antibodies and methods of use
6893845 Surface expression libraries of heteromeric receptors
7049121 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use
7070973 Butyrylcholinesterase variants and methods of use

View more Applied Molecular Evolution patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 624 times since April 2007, the link to the organisation's website has been followed 63 times

Recent Search Terms used to find this page: Fundamental and Applied Molecular Evolution | applied molecular evolutiopn patents | fundamentals molecular evolution | fundamentals of molecular evolution pdf | applied molecular evolution | .

Search for more companies in San Diego

Search for more companies in California



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Applied Molecular Evolution

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.